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Abstract 
Biomimetic nano-assembly formation offers a convenient and bio friendly approach to fabricate 
complex structures from simple components with sub-nanometer precision.  Recently, extract 
from cells of microorganism/plant origin have emerged as a simple and viable route for the 
synthesis of metal and inorganic material nano-particles. In the present study, we have extended 
biological synthesis of nano-particles to organic molecule, namely the anticancer agent, 5-
fluorouracil (5-FU) using Aloe vera leaf extract. The formation of 5-FU nano- particles was 
assessed by UV, FT-IR and fluorescence spectroscopic techniques. Transmission electron 
microscopy and atomic force microscopic techniques confirmed nano-size of the synthesized 
particles. Importantly, the nano-assembled 5-FU retained its anticancer action against various 
cancer cell lines. Finally, the anti-tumor potential of 5-FU nano-particles was established against 
DMBA induced fibrosarcoma in Balb/c mice. 
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Introduction 
Nanosize particles acquire unusual but beneficial properties which may find industrial 
applications in biotechnology as well as other fields with equal propensity (1, 2). The specific 
size of nano-particles is considered to be of great importance for their application as cell marker 
in bio-sensing, bio-imaging and targeted drug delivery etc (1-4). When used as delivery vehicle, 
the nano-size range of the particles of therapeutic importance not only makes them suitable for 
development of systemic, oral, pulmonary, trans-dermal and other routes of delivery but also 
helps in increasing bioavailability, protection of bioactivity, stability and eventually in targeted 
delivery of the drugs. The nano-structured drug particles have the ability to permeate cells and 
connective tissues and thus can be targeted efficiently to the desired biological site without 
clogging the capillaries. It is well appreciated that size of the formulation also regulates its 
uptake by cells that eventually results in greater accumulation of associated drug at the desired 
site.  Once internalized, the drug formulation can be retained by diseased/infected tissues for 
longer time thereby increasing bioavailability and eventually the efficacy of the drug (5).  
 
Biomimetic synthesis of nano-particles is quite common in both single as well as multi cell 
organisms. In multi-cellular organisms, synthesis of hard tissues such as shells, spicules, teeth 
and bones etc takes place through a co-ordinated process; for example; bone formation is 
mediated by osteoblasts while dentinoblasts are responsible for dentin formation (6, 7). In most 
of such naturally occurring structures the particles consist of highly intricate and ordered 
architectures with well defined shapes. Interestingly, the synthesized particles are formed within 
a certain size range, orientation and geometrical symmetry. Various structures thus formed are 
highly organized at molecular, nano and macroscales.  
 
Both bacteria and plant extracts have been lately found to possess unique properties of 
synthesizing metal based nano-particles. In spite of several efforts to dissect various possible 
modes of biomimetic synthesis, it is still not clear that what specific components are present in 
these extracts that lead to formation of nano-assemblies (8). The cytosolic as well as secretory 
components of living cells might offer a template that facilitates formation of nano-assembly in 
an aqueous environment (9-12 Taking a lead from the earlier work on biomimetic synthesis of 
metal and inorganic material nano-particles, we have determined the effect of Aloe vera leaf 
extract on organic molecules. To this end we have used the nucleobase analog, 5-fluorouracil (5-
FU) as a model compound. 5-FU is one of the most potent anti-cancer agents used in the 
treatment of colorectal, head and neck, pancreatic and breast carcinoma. It is a pro-drug that 
requires conversion to 5-fluorodeoxyuridine monophosphate and 5-fluorodeoxyuridine 
triphosphate in cancer cells (13, 14). The drug is also available in the form of ointment based 
formulation that is widely used for topical application (15). 
 
In the present work we describe a simple method to synthesize 5-FU nano particles using Aloe 
vera leaf extract. The synthesized 5-FU nano-particles were characterized by various 
microscopic as well as spectrophotometric techniques. Next, to see whether 5-FU nano-particles 
retain anti-cancer activity, a cell uptake study was done using HT-29 and Caco-2 (human 
adenocarcinoma colorectal) cell lines. We have also examined the apoptotic potential of 5-FU 
nano-particles by targeting the mitochondrial pathway of apoptosis as a possible mechanism of 
cancer chemoprevention. Finally we examined the efficacy of 5-FU nano-particles in treatment 
of dimethyl-benzo-anthracene (DMBA) induced fibrosarcoma in Balb/c mice. 
Results and discussion  
The colorless mucilaginous gel of Aloe vera leaves is widely used as anti-bacterial, 
neutraceutical, anti-inflammatory and immunomodulating agent (16). Recently, it has been 
reported to help in the bioconversion of metals as well as inorganic materials to nano-assemblies 
(12). We wondered whether the potential of Aloe vera leaf extract to form inorganic material 
nano-particles could be extended to organic molecules as well. Surprisingly, it was found that 
incubation of 5-FU with Aloe vera extract ensues in the bio-formation of 5-FU nano-particles.  
 
The biomimetic potential of Aloe vera leaf extract was first established by evaluating its ability 
to convert chloroauric acid (HAuCl4) to nano-sized gold particles (12). Incubation of Aloe vera 
leaf extract with aqueous HAuCl4 solution led to the appearance of a mauve red color in solution 
after about 12 h of incubation, indicating the formation of gold nano-particles (data not shown). 
The gold nano-particle synthesis was further confirmed by visible absorption spectrum of the 
solution that shows characteristic surface plasmon resonance (SPR) band of gold nano-particles 
centered at 560 nm (Figure S1) which were characterized by various techniques. In the next 
phase of study, we used the same leaf extract for preparation of 5-FU nano-particles.  
UV Spectral analysis 
The UV absorption spectra were recorded both for aqueous suspension of 5-FU nano-particles as 
well as its free form (Fig 1A). The free drug absorbs maximally at 271 nm. Mixing of 5-FU with 
Aloe vera leaf extract resulted in instant quenching of 5-FU absorbance. For sake of simplicity 
the observed absorption spectrum was annotated as zero time point observation (Figure 1A). 
Interestingly, longer incubation results in resurgence of absorbance with significant increase in 
intensity of various characteristic peaks of 5-FU in time dependent manner. Following abrupt 
quenching, the resurrection of original peaks with time indicates that synthesized 5-FU nano-
particles too absorb specifically at the same wavelengths. For example, the significant higher 
absorption at ∼245 nm and ∼192 nm suggesting that C=O chromophore along with heteroatom (-
N) containing the conjugated pyrimidine ring remains intact in both free as well as nano-
assembled drug molecules (Figure 1A). The significant blue shift in the region at 272 nm 
suggests that chromophores are actively involved in non-covalent bonding of nucleobase that 
ultimately results in formation of nano-particles. 
 
It has been suggested that microenvironment of chromophoric groups of a chemical compound 
affects the Sπ life-span mainly by tuning the relative energy of the sπ state and the closely lying 
Sn dark state (17). The stability of π-π* transition (in case of 5-FU it is the transfer of an electron 
from the lone pair of oxygen or nitrogen atom towards the more diffuse π* orbital) increases 
both with the polarity, and especially the hydrogen bonding ability of 5-FU with the external 
milieu, implying that with such microenvironment, the dynamics of Sπ is not influenced by Sn. 
Moreover, since the nano-particle formation is providing relatively less polar environment when 
compared to that of free form of the drug, it eventually results in broadening of the absorption 
spectrum. It seems in nano-particle the external milieu of an individual 5-FU molecule modulate 
π-π* as well as n-π* transition (17, 18). 
 
The concentration dependent kinetics of nano-particle synthesis is more intriguing. At a fixed 
time point (12 h) the absorbance was found to decrease upon addition of Aloe vera leaf extract (1 
ml Aloe extract; final volume of reaction mixture 10 ml) to 5 ml of 10-3 M 5-FU solution (Figure 
1B). Aloe vera mediated transformation of drug to nano-size assembly results in considerable 
decrease in the absorption peaks. However, mixing of drug with relatively larger ratio of Aloe 
vera extract (3 ml Aloe extract and 5 ml of 10-3 M 5-FU solution in final volume of the 10 ml) 
brings about an increase in absorbance. Further increment of Aloe vera extract content to 5-FU (5 
ml extract and 5 ml of 10-3 M 5-FU solution in final volume of  10 ml) ensued in additional 
increase in peak intensity bringing the curve nearer to that of free form of  drug. This clearly 
suggests that higher concentration of the active components of Aloe vera leaf extract facilitates 
ready formation of drug nano-particles without changing the chemical structure of the parent 
nucleobase.  
Fluorescence spectra analysis  
The nucleobase 5-FU is highly fluorescent, possessing characteristic excitation and emission 
wavelengths (17-19). Addition of Aloe vera leaf extract to 5-FU resulted in quenching of 
fluorescence intensity (Figure 1C). The observed decrease in relative fluorescence intensity of 5-
FU does not seem to be due to the interaction of fluorophore moieties of the compound with Aloe 
vera leaf extract components that come in contact to each other during process of nano-particle 
formation (20, 21). Rather, the observed quenching can be attributed to the active involvement of 
fluorophore in interaction between various 5-FU molecules constituting the nano-particles.  In-
fact, the fluorescence spectra of free 5-FU suggest that at least 4 different fluorophore species are 
responsible for fluorescence behavior of 5-FU. Among these C=O and –NH- are the main 
contributors. The fluorescence emissions are also contributed from vibrational modes involving 
C5-C6 stretching as well as out of plane motion of carbonyl groups.  
 
The noticeable feature that concerns the relative energy of the first absorption band (SO→S1) 
which corresponds to a π→π* transition. The energy trends can be correlated with the shape of 
the orbits involved in the SO→S1 transition. The fluoro group at C5 position gives an anti-
bonding contribution to the frontier orbitals, thereby making them less stable. It can be inferred 
that when substituent at C5 position (cf. -fluoro) gives rise to hyper conjugation effect, the S→S1 
transition is shifted towards lower energy as compared to uracil (17, 18). On the contrary, an 
increase in electron density on the C4 carbonyl group is likely to be responsible for the Sπ 
stabilization. During nano-assembly formation, the weak ionic interaction between C=O as well 
as –NH- groups might be facilitating the stacking of 5-FU molecules and that in-turn leads to 
abrupt quenching of nano-formulation. As more than one fluorophore species are involved in 
fluorescence event, quenching is more prominent for the fluorophores which are directly 
involved in nano-particle formation. 
 
In aqueous environment, 5-FU shows hydrogen bonding that involves formation of H2O shell 
around the periphery of each molecule. Upon nano-particle formation, 5-FU molecules adopt a 
three dimensional frame work where inter-molecular hydrogen bonds provide sufficient stability 
to the particles. The observation that 5-FU nano-particles retain fluorescence characteristic of the 
parent nucleobase again led us to believe that Aloe vera extract helps in assemblage of nano-
particles of 5-FU. Further, in the 5-FU nano-particle, various molecules have been oriented in the 
fixed position by non-covalent linkages as there is no significant change in the fluorescence 
characteristic of 5-FU. It has been suggested that Sπ arises mainly from the HOMO→LUMO 
excitation with π/π* character, whereas Sn has predominant HOMO-1→LUMO character (n/π*) 
(17, 18). Incidentally various moieties that participate in hydrogen bonding are responsible for 
n/π* and π/π* electronic character of 5-FU as well. 
 
The observed change in fluorescence pattern can also be correlated with shape and size of the 
particles as in the next section, which deals with transmission electron microscopic studies; we 
clearly observed an effect of increase in Aloe vera leaf extract concentration on size of the 
synthesized particles. Less amount of Aloe vera leaf extract results in relatively large sized nano-
particles, which show less fluorescence intensity due to quenching. Higher ratio of leaf extract to 
drug solution leads to synthesis of relatively small sized nano-particles, eventually resulting in 
lesser quenching and higher fluorescence intensity. The observed quenching in the relative 
fluorescence can be attributed to the assemblage of 5-FU molecules in nano-sized particles.  
The fluorescence spectrum shown in figure 1C, clearly demonstrates that left shoulders are 
significantly blue shifted. This trend can be rationalized on the ground of the shape of the 
frontier orbitals of 5-FU and on the increase of dipole moment upon electronic excitation (17, 
18). The observed blue shift upon nano-particle formation indicates that fluorophores are 
experiencing relatively less polar environment. As explained for the observed quenching of 
relative fluorescence this situation is possible when 5-FU molecules are stacked upon each other 
thereby leading to the formation of compact particulate assembly. The observed change in 
pattern of fluorescence intensity suggests a role of intermolecular hydrogen bonds in modulating 
the interplay between dark and bright states, and, consequently, the excited state life time of 5-
FU. The fluorescence data, obviously related to the complexity of the excited state decay 
mechanism, suggest that more than one factor are operative in regulating observed fluorescence 
quenching.  
Fourier Transform Infrared Analysis 
The 5-FU nano-particles were also characterized by Fourier Transform Infrared (FT-IR) analysis, 
with the assumption that assembled structures might be ensuing in burial/exposure of various 
functional groups of parent compound that might lead to changes in corresponding percent 
transmission intensity (22). Figure 4 shows the infra red spectra of 5-FU nano-particles, in the 
region of 900-1800 cm-1, obtained under various experimental conditions. FT-IR spectra of leaf 
extract (spectrum I) shows many intense peaks. Absorption at 1542 cm-1 is the characteristic of 
polyunsubstituted mononuclear ring and a shoulder near 1730 cm-1 is due to C=O stretching of 
carbonyl compounds. This is in accordance with some previous FTIR studies on the same extract 
(9).  The spectrum of the drug (spectrum II) shows a prominent peak at 1255 cm-1, which is due 
to the stretching of C=O bond of aryl ketone and absorption at 1692 cm-1 is characteristic feature 
of secondary amine in solution as there are two –NH groups in the 5-FU. The spectrum of free 
drug shows band in the region 1580-1650 cm-1 corresponding to the C=N and C=C ring stretched 
vibration. The absorption band at about 1724 cm-1 may be due to the stretching frequency of 
C=O group. The bands at 1450 cm-1 and 1350 cm-1 are characteristic for vibration of the 
substituted pyrimidine compounds (23). The absorption bands at 1180 cm-1 and 1251 cm-1 are 
assigned to the C-O and C-N vibration respectively.  
In the spectrum of 5-FU nano-particles (spectrum III and IV) most of the prominent peaks of the 
parent compound are retained. This suggests that no major change in the chemical structure of 5-
FU has occurred upon nano-particle formation. For example, prominent peaks at 1255 cm-1, 1692 
cm-1, 1542 cm-1, 1579 and 1730 cm-1 are shared between nano-structured and free form of 5-FU. 
In addition, there are new and intense peaks at 1019 and 1468 cm-1, which arise due to exposure 
or burial of functional group in nano-structure. The appearance of new peak at 1019 cm-1 could 
be because of in plane C-H bending of compound in assembled nano structure. It can also be 
assumed that  the peak at 1019 cm-1 is due to formation of S=O group and the S came from the 
Aloe vera extract as there is no S in 5-FU molecule. In another explanation, absorption at 1019 
cm-1 could be considered as a probe for aryl ether (Ar-O-C) which is probably formed due to 
complex formation between the aromatic compounds present in the Aloe vera extract and C=O 
moiety of drug. This peak may be due to C-H bending of aromatic ring in plane as well. It is not 
clear whether absorption at 1468 cm-1 is due to C-H bend of δs CH2 of pyrimidine ring originating 
from the 5-FU nano-particles or due to C-C ring stretching of new complex resulting from the 
reaction between Aloe vera leaf extract and 5-FU. Our FTIR analysis of free form of drug and 5-
FU nano-assemblies in the range of 2400-2300 cm-1 revealed similar pattern in both the cases 
(Data not shown). We speculate that attainment of particle shape could be the result of either an 
enzymatic reaction or templating of specific macromolecule that regulates growth kinetics. 
TEM analysis of synthesized nano-particles. 
Figure 2 shows representative transmission electron microscopy (TEM) image of the 5-FU nano-
particles synthesized by using Aloe vera leaf extract. TEM analysis clearly revealed the 
formation of hexagonal 5-FU nano-particles. Further studies involving incubation of increasing 
amount of Aloe vera leaf extract with constant amount of drug reveals formation of 
nanostructures with different shape and surface topology. The size and edge length were found to 
decrease when higher volume of Aloe vera leaf extract was used for synthesis of nano-particles. 
Addition of small amount of Aloe vera (1 ml Aloe vera extract and 5 ml of 10-3 M 5-FU solution; 
final volume of reaction mixture 10 ml) leads to the formation of particles with large and slightly 
rough edge length (data not shown). However, a different trend was observed when the amount 
of Aloe vera extract was increased from 1 to 5 ml that results in the formation of hexagonal 
nano-particles with sharpe edge length (Figure 2A). The bar diagram representing the size 
distribution of the particles is shown in Figure 2C. A symmetrical edge length analysis of the 
HRTEM image of a single hexagonal nano-particle noticeably highlights the difference in size 
and shape of the formed nanostructure (Figure 2B). It can be speculated that incubation of 5-FU 
solution with relatively large proportion of Aloe vera leaf extract leads to the formation of 
hexagonal structure due to the Multiple Twinned Particles (MTPs). Xia and co-workers (24, 25) 
have observed that nanostructures evolve from MTPs as a result of anisotropic growth caused by 
certain shape directing agents. We assume that MTPs play a vital role in the formation of 5-FU 
hexagonal nanostructure. The formation of isomorphic particles with hexagonal shape indicates 
that crystallographic plane has highest atomic density. In general, particles with plate 
morphology grow faster than those with symmetrical shape.  
The size of 5-FU nano-particles was further confirmed by nanofox particle analyzer. The size 
distribution of the particles was observed by digital analysis of image counting of particles. A 
sharp peak around 45 nm emerged as a single predominant peak which further supports our TEM 
data (Figure 2D). Size of the 5-FU nanoparticles was also analyzed by dynamic light scattering 
studies. The distribution of particle diameters showed prominent peak at 35 nm along with some 
insignificant peaks which further strengthens our data (Figure 2E). The size distribution studies 
reveal that the particles are more or less mono-disperse with average size of 35±5 nm and further 
establish that the particle size decreases with an increase in the concentration of Aloe vera leaf 
extract. 
Although, it has been the subject of numerous recent investigations (26-29), a coherent 
mechanistic explanation for the evolution of various metal nano-particles prepared via chemical 
or biomimetic methods has not been delivered yet. A mechanism of nano-particle formation was 
proposed by Polte et al (8) comprising different steps of particle growth via both coalescence of 
nuclei and further monomer attachment. Nevertheless, the nature of the ‘directing effect’ is still 
not clear. Researchers claim that it is due to preferred absorption of the capping agent to the 
surface (30, 31) while others propose that the formation of stacking faults during the first 
nucleation events is the main factor for asymmetric growth of nano-particles (32, 33).  
Our preliminary studies suggest that treatment of Aloe vera extract with Proteinase K, DNAse or 
RNAse does not affect its ability to facilitate of 5-FU nanoparticles. In an attempt to identify 
various components of Aloe vera leaf extract responsible for particle formation, we dialyzed the 
extract using a membrane with 3 kD cut off. The components, which regulate induction of nano-
particle formation, were found to be less than 3 kD molecular weight as extract when passed 
through the dialysis bag loses 90% of its activity. We also found that even after complete 
precipitation with 80% ammonium sulphate the extract was still capable of inducing formation of 
both gold and 5-FU nano-particles (Data not shown). Further, it was found that boiling of extract 
for 15 min does not eliminate its nano-particle synthesis potential (Data not shown). These 
results are in accordance with work from other groups suggesting that a water soluble, low 
molecular weight compound was responsible for synthesis of nano-particles (12). 
Determination of zeta potential of nano-particles 
It is well established that size and surface charge of the particles play a major role in its uptake by cells 
(34). Further, surface charge, which is generally denoted as zeta-potential, acquired by a particulate 
system regulates the half life of a particle in vitro as well as in vivo. Keeping into consideration the fact 
beside nano size the surface charge stability of nano particles, we determined zeta potential of 5-FU nano-
particles that was found out to be -0.75± 0.05 mV, which suggest that particles can withstand biological 
fluid milieu upon their administration in the host (34).  
 
Crystalline nature of 5-FU nano-particles 
Even though TEM analysis offered direct evidence regarding formation of 5-FU nano-
assemblies, the crystalline structure of nano-assemblies was not established. For this reason, X-
ray diffraction study of nano-assemblies was performed and compared with free 5-FU. 5-
Fluorouracil is known to exist in two crystalline forms. Form I (35) crystallizes in space group Pī 
and exhibits an intricate, hydrogen-bonded sheet motif with four crystallographically 
independent molecules with regions of close F•••F contacts. The recently discovered form II (35) 
(P21/c, Z’ = 1) adopts a hydrogen-bonded ribbon motif, with each molecule forming four NH•••O 
bonds with two adjacent molecules. The layers stack as the (-1 0 2) Miller planes to form the 
three-dimensional crystal structure (36). A crystal structure prediction search for lattice-energy 
minima (36) found form II as the most stable packing arrangement. Recent molecular dynamics 
simulations (37) suggest that the presence of water enhances the growth of form I, as both 
carbonyl and amine functional groups remain strongly solvated and, hence, their association into 
dimers is hindered; while nitromethane facilitates the formation of form II. On the basis of above 
mentioned fact, we speculate that exclusion of water molecules during nano-assembly formation 
resulted in 5-FU molecules acquiring form II, which also gets support from florescence data that 
dimerisation/polymerisation and collisional quenching interactions between fluorescent moieties 
during process of nano assembly formation leads to fluorescence quenching (38). As shown in 
Figure 2F and 2G,  X-ray diffraction patterns of nano-assemblies revealed the crystalline nature 
of  nano-particles synthesized from 5-FU with the help of Aloe vera extract. As depicted in 
figure the peaks were more prominent when compared to the peaks of free form of 5-FU near the 
base line at 2θ of 15°-30°. The X-ray diffraction data confirmed that upon nano-paricle 
formation components maintained their native crystalline structure. Supporting electron 
microscopy results, the XRD data suggest hexagonal structure of 5-FU nano-particles. X-ray 
diffraction spectrum of pure 5–FU show characteristic intense peaks at diffraction angle with 2θ 
at 16°, 19°, 22°, and 28°. X-ray diffraction peaks for free 5-FU were found to have more or less 
same diffraction pattern except between 2θ of 35°-50° of the nanoparticles. Our XRD studies 
confirmed that nano-assemblies share the same Miller indices with the free form of drug. The 
most prominent peak (at 2θ of 27.79) showed the same Miller planes (2 -1 2) in both cases with 
d-spacing of 3.16 Å. Finally, the XRD data clearly suggest that the structural integrity is retained 
by 5-FU nanoparticles. 
Atomic Force Microscopic Analysis  
Figure 2 H shows representative Atomic Force Microscopy (AFM) images of nano drug 
formulation prepared using 5 ml of Aloe vera leaf extract after 48 hr. A number of hexagonal (or 
similar to hexagonal) nano-particles were observed in these images. Nano-particles can be seen 
overlapping or in the form of clusters and assemblies supporting TEM data. In concordance with 
TEM and DLS studies, size of nano-particles was found out to in 30-50 nm range when tracked 
with 2D image. The height of the 5-FU nano-particle feature is exaggerated for better perception 
of the fine structures. The AFM also measured height data as visualized with single surface 3D 
AFM. 
Release of drug from 5-FU nanoparticles 
To show that the nano-assemblies can act as a reservoir of 5-FU and facilitate the sustained 
release of the drug for extended time period, release profile of nano-particles was examined. For 
this multiple samples of 5-FU nano-particles were dispensed in various micro vials. The release 
profile showed slow and sustained release of drug  over an extended time period. The kinetic 
release assay indicates stability of nano-particles under different conditions. The nano-particles 
were found to withstand plasma components for a period of more than 120 hr resulting in release 
of less than 40% of the total drug (Figure 3 A).  
Cytotoxic potential of 5-FU nano-particles  
The cytotoxic potential of formed 5-FU nano-particles against various cell lines, HT-29 and 
Caco-2 cell lines was assessed by determining the number of viable cells surviving after their 
incubation with drug for stipulated time period using MTT (3-(4,5-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium) method (39). The cytotoxicity assay 
suggests that 5-FU nano-particles exhibit various degree of cytotoxocity against different cancer 
cell lines. The cytotoxic effect of 5-FU was more prominent against HT-29 and Caco-2 cells and 
the IC50 of free 5-FU was found to be 0.30 and 0.34 µM respectively. Ability of 5-FU 
nanoparticles to inhibit growth of both the cancer cell lines was found to be time dependant. The 
IC50 of 5-FU nano-particles was 0.21 µM against Caco-2 cells, while the IC50 of 5-FU nano-
particles against HT-29 cells was 0.25 µM (Figure 3 B).  
Apoptosis and cell cycle analysis 
The anticancer potential of nano-particles was assessed on the basis of expression of various 
apoptotic factors in treated cells. The pro-apoptotic gene p53 is a key regulator of cell 
proliferation and cell death (40). Normal cell cycle events are tightly regulated by cyclin, cyclin-
dependent kinases (CDK), CDK inhibitors (CDKI) and other tumour suppressor genes. The 
deregulation of cell cycle leads to abnormal proliferation of cells with damaged DNA and 
evasiveness of apoptosis (41). Cell cycles are halted at the transition from G1 to S-phase (G1 
checkpoint) or from G2 to M-phase (G2 checkpoint) after DNA damage (42). 5-FU is generally 
believed to induce G1-S-phase arrest of cells, thus halting their progression from G1 to S phase 
during their cell cycle and subsequently paving the way for apoptosis of the cancer cells via a 
p53-dependent pathway (43). Other studies have also suggested its role in inhibition of cell 
progression at G2/M phase (44). 
 
We extended our study to gain an insight in 5-FU nano-particle mediated modulation of various 
factors that regulate apoptosis. Western blot analysis was performed to detect level of various 
cell cycle and apoptotic factors. Incubation of 5-FU nanodrug formulations with cancer cells 
resulted in enhanced expression of p53wt when compared to free form of the drug (Fig 4A). 
Mutations in p53 gene are commonly found in a majority of malignancies. In fact, more than 
50% of advanced skin tumor harbor mutations in the p53 gene (45). The p53 protein is known to 
mediate cell cycle arrest (46) and also acts as a transcription factor that binds to a p53-specific 
DNA consensus sequence in responsive genes such as p21 (47).  5-FU nanodrug formulation 
down regulates the expression of p53mut (two fold decrease) thereby enhancing apoptosis 
induction in cancer cells. In the control groups the expression profile of these proteins was not 
significantly affected suggesting that nano-assembled 5-FU is more effective in down regulating 
p53mut gene expression when compared with free form of the drug. We also analyzed the 
expression profile of p21 and cyclin B1 and found that nano-drug formulation enhances the p21 
protein level comparable with free 5-FU. In the presence of 5-FU nano-formulation, cyclin B1 
expression was also found to be strongly with its level decreased by 2.5-fold. 5-FU nanoparticles 
could induce the expression of bcl-2 and bax as efficiently as the free form of the drug. The 
elevation of bax protein level in 5-FU nano-particles treated cells (Figure 4 A) can be correlated 
with the involvement of mitochondrial (intrinsic) pathway in apoptosis in which there is 
reduction of mitochondrial membrane potential that eventually ensues in cytochrome c release 
and subsequently leading to caspase activation.  
In-vivo studies of proapototic factors such as p53 and Bax are crucial for regulating the growth 
and death of cells, the presence of these proteins was, therefore, used as one of the parameter to 
study the anti-cancer effect of nano-assemled drug. A compartively high expression level of bax 
and p53 wt proteins was recorded in animals treated with 5-FU nanoparticles drug when 
compared to animals treated with cream base and Aloe vera leaf extract only with cream base. 
Down regulation of bcl-2 and p53 mut was also observed in animals treated with nano-assembled 
5-FU drug whilst upregulation of both proteins occurred in animals treated with cream base and 
Aloe vera only with cream base (Figure 4 B). 
Flow cytometry based cell cycle analysis of, cancer cells showed 60.33% cells in G0/G1, 14.60% 
in S, and 2.41% in G2/M phase before exposure to various 5-FU formulations. Treatment of 
cancer cells with 5-FU formulations resulted in increased intra-S cell cycle arrest (14.84% for 5-
FU alone and 16.05% for 5-FU nanoparticles), as well as the arrest of cells in G2/M phase. 
Following exposure to 5-FU, greater G2/M-phase accumulation (4.14% vs 2.41% for 5-FU vs 
control) was observed. Furthermore, treatment with 5-FU nanoparticles potentiated the effect of 
5-FU alone and resulted in the arrest of cells to the G2 phase of the cell cycle almost as 
effectively as the free form (4.49%) (Fig 5 B). Apoptotic cells, which appeared in a region to the 
left of the G1 peak, accounted for 20.12% for free 5-FU alone and 19.29% for nano form of 
drug, which clearly established that in-house prepared nanoparticles maintained then cytotoxic 
potential and resulted in the inhibition of G2/M progression. 
 
Caspases are crucial mediators for apoptosis we evaluated the expression of caspase-9 upon 
treatment with 5-FU nanoparticles with the help of confocal microscopy. Caspase-9 is the apical 
caspase in the intrinsic pathway (48); initiated by cytochrome c released from the mitochondrial 
intermembrane space into the cytosol (48) that eventually induces apoptosome formation. 
Expression of caspase-9 was found to be enhanced in a time-dependent manner for 5-FU 
nanoparticles when compared to the free form of the drug (Fig 5 A). In case of untreated cells, no 
increase in the expression of caspase-9 was observed at any time point. Caspase-9 activates the 
effector caspases-3 and -7, which cleave several other cellular proteins, resulting in the 
characteristic biochemical and morphological features associated with apoptosis. It seems 5-FU 
nano form has great potential in induction of csapase-9 and thereby facilitates apoptosis of cells 
more efficiently when compared to its free form. 
 
The up-regulation of p53 together with down-regulation of bcl-2 expression following 5-FU 
treatment may partially account for the mechanism involved in 5-FU induced apoptosis in the 
cells. Of note, both p53- and/or p21- dependent and independent pathways have been previously 
reported to be involved in 5-FU induced cell cycle arrest and apoptosis in cancer cells; the cell 
responses varied and the mechanisms may be attributed to the specific cell types involved and 
the doses of anticancer agents used (44, 49). Our studies indicate that at low concentration 5-FU 
nano-particles arrest cells at G2/M phase. This is in accordance with  earlier reports that have 
mentioned effect of free 5-FU on G2/M phase at relatively low concentration, while high 
concentration of the drug maintained cells in  G1 phase (44). Besides, the nano-particles were 
also found to upregulate pro-apoptotic factor in a manner similar to free form of the drug. 
Nevertheless, nano-particles were found to exert their effect more efficiently as equal amount of 
nano-particles caused approximately three fold increase in p53 wild type and more than two fold 
decrease in p53 mutant expression when compared to its free form.  
DNA fragmentation as analyzed by Apo-BRDU study using flow cytometer and with the 
help of Annexin V 
DNA fragmentation during apoptosis is one of the main steps of our study, in this process which 
results from the activation of endonucleases during the apoptotic program. The nuclease leads to 
the higher order chromatin structure into fragments and subsequently into smaller DNA pieces. 
Cells were collected after treatment from their respective groups (Figure 5 C.  C1. Untreated 
Control, C 2. Drug only, C 3. 5-FU nano-particles prepared by mixing of 5-FU (10-3 M) solution 
with 3 ml of aloe vera extract and C 4, 5-FU nano-particles prepared by mixing of 5-FU (10-3 M) 
solution with 5 ml of aloe vera extract) and cells were fixed by using a DNA cross-linking 
chemical fixative (e.g. paraformaldehyde).  Efficacy of Nano particle was observed by Brdu 
tunnel analysis by FACS. The enzyme TdT catalyzes a template dependent addition of Br-dUTP 
to 3-hydroxyl ends of double and single stranded DNA. After incorporation, DNA breaks sites 
and identified by a FITC-labeled anti-BrdU mAb. Apoptosis induction as evident by expression 
was significantly enhanced in nanoparticles treated cells (C4, 34%) as compared to free form of 
drug and untreated control cells showed 12% and 4.31% positive apoptotic cells respectively. 
Annexin V apoptosis detection via fluoresces microscopy  confirm, apoptosis induction as evident 
by fragmentation of chromatin strucutre was significantly enhanced in cells treated with nanoparticles 
(Figure 5 D 4). Moreover, there was no expression of Apoptosis in untreated cells (Figure 5 D 1).  
The histopathological analysis of tissue treated with various formulations again established 
higher efficacy of 5-FU nano particles. Animals treated with cream base or Aloe vera only with 
cream base demonstrated papilliomatous growth, moderate aconthosis and mild keratosis, 
complex fibrovascular core with congested vessels and loss of pilosebaceous units. The animals 
treated with free 5-FU showed papilliomatous change, heavy aconthosis and heavy kerayosis. On 
the other hand, animals treated with nano-assembled 5-FU resulted in sessile to pedunculated 
papilliomatous change, heavy aconthosis and marked keratosis (Figure 6). 
Conclusion  
Biomimetic synthesis of nano-particles using biological entities is considered as a clean, 
nontoxic and environment friendly technique. Earlier reports have documented usage of plants 
such as oat (Avena sativa), lemongrass (Cymbopogon flexuosus), neem leaf broth (Azardirachta 
indica), amla (Emblica officinalis), cinnamon (Cinnamon camphora) and Aloe vera  leaf extract 
in synthesis of metal (gold, silver, iron and cadmium) based nano-particles. Surprisingly, 
methods of extending these approaches to organic molecules, such as cancer drug based nano-
particles, have not yet been explored. They are highly desirable owing to superiority of nano-
particles dosage forms over free form of the drugs. Transformation of parent drug molecules to 
nanometer size scale can result in their high uptake across biological membranes. Furthermore, 
nanosized drug assemblies that are devoid of any pharmaceutical excipients, are prerequisite for 
preparation of more efficacious formulation (Figure S 2). Such formulations avoid issues 
pertaining to biodegradability or biocompatibility etc of various carriers used in conventional 
dosage forms.  
In the present study, we have explored the potential of Aloe vera leaf extract in synthesis of 5-FU 
nano-particles. First, we determined the effect of increasing amount of Aloe vera extract on 
synthesis of 5-FU nano-particles. It seems that characteristics features of nano-particles spectra 
are regulated by shape and size of the particles. Discrete optical transitions have been observed 
in monodisperse nano-particles system of 5-FU. Both UV and fluorescence spectra show a 
consistent blue shift as the size of particles increases. In fact due to their large size, light cannot 
polarize the nano-particles homogenously and retardation effect leads to the excitation of higher 
order modes (50). The synthesis of 5-FU nano-particles was further confirmed by TEM, FT-IR 
and AFM. All these results correlate well with each other and confirmed the formulation of FU 
nano-particles.  
The nano size of the delivery system is considered of great importance in uptake of the drug by 
cell target. To confirm our hypothesis we performed a set of in-vitro experiments and finally 
evaluated its potential against skin fibro sarcoma  in model animals. In both cases, 5-FU nano-
particles show more anti-tumor activity compare to the free form of drug. This was confirmed by 
Western blot analysis of the expression of p53 and cyclin-B1, the two most important pro-
apoptotic factors. The nano-particle formulation of the drug markedly down regulation the 
expression of anti-apoptotic gene when compared to free form of the drug.  
Current research areas in the field of cancer chemotherapy include development of carriers to 
allow alternative route of drug administration. The combination of drug and Aloe vera leaf 
extract resulted in development of nanoassemblies of 5-FU that are more potent when compared 
to the free form of drug  and need to be explored further  for their use in treatment of cancer in 
animal models. Nanomaterials are at the leading edge of the rapidly developing field of 
nanotechnology. Till now various technologies have been exploited to develop nano-particles.  
The nano size of the material makes them unique and indispensible in many area of human 
activity. Biological synthesis of the nano-particles has remained focused on synthesis of metal, 
however, present study, relying on potential of biomimetic synthesis of organic molecules, opens 
new vistas in cancer therapy. The exact picture regarding effectiveness of the formulation of 5-
FU nano-particles can be obtained if we introduce tiny nanobodies into animal models for cancer 
therapy. At present we are exploring such developments with the hope that soon it will be 
possible to introduce novel nano-particle formulations that will not only be more effective but 
would also be devoid of nano-particle associated putative toxicity constraints. Our preliminary in 
vivo study showing potential of 5-FU nanoparticles in treatment of skin cancer in model animals 
one such step that opens new vistas for cancer therapy. 
Statistical analysis. Statistical analysis performed using student’s t-test. Differences were 
considered statistically significant with P value <0.05. 
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Figure legends 
Figure 1. (A) UV spectra of 5-FU nano-drug formulation 5-FU solution was incubated with Aloe 
vera extract (5 ml of 10-3 M 5-FU and 5 ml Aloe vera extract; final volume of reaction mixture 
10 ml) for specified time period (0- 24 h). The incubation mixture was scanned in UV range to 
analyze characteristic peaks. The spectrum shown at zero time point actually corresponds to 5-
FU nanoparticles obtained instantly just after intial mixing of free 5-FU with aloe vera leaf 
extract. (B) UV spectra of 5-FU nano-particles synthesized using increasing amounts of Aloe 
vera extract as mentioned in graph. (C) Emission spectra of 5-FU nano-particles synthesized 
using Aloe vera extract. The 5-FU solution (10-3 M) was incubated with increasing volume of 
Aloe vera extract and scanned using spectrofluorimeter. The excitation wave length was 260 nm. 
(D) FTIR spectra of 5-FU nano-particle synthesized by reacting 5-FU solution (10-3 M) with 
increasing volume of Aloe vera extract.  spectrum 1; Aloe vera extract, spectrum II; 5-FU only, 
spectrum III;  5-FU nano-particles synthesized with 3 ml of Aloe vera extract, spectrum IV; 5-FU 
nano-particles synthesized with 5 ml of Aloe vera extract. All the FTIR spectra were recorded 
after 48 hr of incubation. 
Figure 2 (A) Representative TEM image of 5-FU nanoparicles synthesized by incubating 5 ml of 
10-3 M 5-FU solution with 5 ml of Aloe vera extract for 48 h. (B) TEM image of the plate like 
hexagonal 5-FU nano-particles prepared from 5-FU (10-3M) with Aloe vera leaf extract (5ml). 
HRTEM image shows different section of hexagonal nano-particles of 5-FU. (C) Variation in 
particle size diameter upon incubation of 10-3 M 5-FU solution (5 ml) with 5 ml Aloe vera 
extract for 48 h. (D) Corresponding particle analysizer data as obtained by Nanofox particle 
analyzer. (E) Graph showing size of the nano-particle as obtained by Dynamic Light Scattering 
studies. The X-ray diffraction pattern of both free 5-FU, and 5-FU nano-particles, shows 
characteristic intense peak at diffraction angle (2θ) of 16°, 19°, 22° and 28°. X-ray diffraction of 
5-FU and nano-particles of 5- FU synthesized using Aloe vera plant extract. At diffraction angle 
(2θ) of (F) 20-30 and (G) 25- 30 respectively. (H) Representative AFM image of 5-FU nano 
particles synthesized by incubation of 5 ml of 10-3 M 5-FU with 5 ml Aloe vera extract for 48 hr.  
2D, 3D images of 5-FU nano-particles and Histogram of AFM. 
Figure 3. Release profile of 5-FU nano-particles under different conditions. To examine the 
release kinetics of 5-FU nano-particles, multiple samples of the formulation were dispensed into 
various micro vials. To each vial, 1.0 ml of release medium (20 mM sterile PBS, serum or 
histidine buffer) was dispensed. After stipulated time period, the suspension was centrifuged and  
an aliquot was analyzed for 5-FU content, spectrophtometrically as described in materials and 
methods section. (B) Cytotoxic effect of 5-FU nano-particles aganist (A) HT-29 and (B) Caco-2 
cell lines. MTT assay was used to determine the differential cytotoxicity of 5-FU nano-particles 
against both cell lines. Cells were dispensed at the density of 5 x 104 cells per well in U-bottom 
96 well plates in triplicate, and treated with increasing concentration of various 5-FU nano 
formulations. After 48h of incubation, 20 µl of MTT reagent was added and plate was further 
incubated for 48 hr. It was followed by addition of 100 µl of lysis buffer. The plates were further 
incubated for 2 hr and absorbance was read at 570 nm. 
Figure 4. (A) Effect of 5-FU nano-particles on expression of pro/anti apoptotic factors in Caco-2 
cell line. Cell lysates were prepared as described in Materials and Methods and analyzed for 
protein expression using specific antibodies. To quantify equal loading, the membranes were also 
probed with β-actin antibody. The intensity of bands was quantified using image analysis 
software on an image gel documentation system. Lane 1, RPMI only; Lane 2, Aloe vera leaf 
extract only; Lane 3, 5-FU only; Lane 4, 5-FU nano-particles prepared by mixing of 5-FU (10-3 
M) solution with 3 ml of aloe vera extract and Lane 5, 5-FU nano-particles prepared by mixing 
of 5-FU (10-3 M) solution with 5 ml of aloe vera extract. (B) Effect of 5-FU formulation on  
expression of various apoptotic molecules in skin tumors of Balb/c mice. Lysates from skin 
tumors were prepared as described in Materials and Methods. Lysate proteins were resolved with 
electrophoresis and analysed for expression of various apoptotic factors. To ensure equal 
loading, membranes were probed with β-actin antibody. 1) Normal healthy mice 2) Skin with 
tumors in mice exposed to DMBA followed by treatment with cream base only. 3) Skin with 
tumors in mice exposed to DMBA followed by treatment with Citrus fruit along with cream 
base. 4) Skin with tumors in mice exposed to DMBA followed by free 5-FU with cream base. 5) 
Skin with tumors in mice exposed to DMBA followed by treatment with 5-FU nano-particles 
with cream base. 
Figure 5. (A)  Involvement of caspase-9 in 5-FU mediated apoptosis of Caco-2 cells as reveled 
by confocal microscopy. Caco-2 cell, were treated with (a) RPMI only, (b) free 5-FU drug, and 
(c) 5-FU nano-particles for 24 h. After stipulated incubation period with various 5-FU 
prepration, cells were washed and fixed with 4% paraformaldehyde, 0.19% picric acid in PBS 
(pH 7.4) for 1 h at room temperature (RT). Fixed cells were permeabilized with 0.1% SDS in 
PBS at RT for 10 min, blocked with 2% FCS, stained with a polyclonal antibody which detects 
only cleaved 35 kDa caspase-9 (BD, India) and revealed with a conjugated goat anti-rabbit IgG-
FITC probe (Sigma, India). The cells were then visualized under a fluorescence microscope 
(excitation at 488 nm emission at 505-530 nm.) scale bar, 10 µm. (B) Effect of 5-FU nano-
particles on cell cycle arrest. Caco-2 cells were incubated with various 5-FU nano particles 
followed by treatment with propidium iodide. Propidium Iodide fluorescence was measured 
using flow cytometer with FL-2 filter and was expressed as histogram. (A) Cells treated with 
RPMI, (B) cells treated with Aloe vera extract only, (C) cells treated with free 5-FU only and (D) 
cells treated with 5-FU nano assemblly. The effect of 5-FU nano-particles was observed as 
reduction in sub G1 peak. (C) DNA fragmentation as analyzed by Apo-BRDU study using flow 
cytometer (D) Annexin V apoptosis detection via fluoresces microscopy. 
Figure 6 (A) Histopathological studies of animals after treatment with 5-FU nano formulation. 
(A) Untreated group with profuse papillomatous growth, moderate acanthosis, and marked 
keratosis, complex fibrovasciular core with congested vessels and loss of pilosebaceous units. 
(B) Citrus fruit group (C) Free 5-FU treated group. (D) 5-FU nano-particles treated group.  
(Figure B) Effect of 5-FU nano particles on DMBA induced skin cancer in Balb/c mice. Balb/c 
mice were exposed to DMBA to induce skin tumor following method as described in 
methodology section. The animals with skin tumor were subsequently treated with a) cream base 
only. b) Aloe vera leaf extract along with cream base. c) Free 5-FU along with cream base. d) 5-
FU nano-particles along with cream base. (C) Effect of  5-FU nano-particle treatment on survival 
of animals with DMBA induced skin cancer. Survival data show the efficacy of 5-FU nano-
particles formulation in terms of percent survival at various post treatment time points. 
 
 
 






